Obsidian Therapeutics Inc.(OBX)

Biotechnology · Cambridge, MA

$13.22-0.62 (-4.48%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T21:13:04.720Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:13:04.720Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow: N/A
Quote market capitalization: 13,750,386

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

OBX Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

OBX Competitors' Operating Cash Flow Yield

OBX

Obsidian Therapeutics Inc.

Current

Market Cap

$13.75M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SINT

Sintx Technologies, Inc.

vs OBX

Market Cap

$13.86M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLSM

Pulsenmore Ltd. Ordinary Shares

vs OBX

Market Cap

$14.05M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INAB

IN8bio, Inc.

vs OBX

Market Cap

$13.33M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OPTH

Optimi Health Corp.

vs OBX

Market Cap

$13.30M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CTXR

Citius Pharmaceuticals, Inc.

vs OBX

Market Cap

$13.20M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PASG

Passage Bio, Inc.

vs OBX

Market Cap

$13.11M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HIND

Vyome Holdings, Inc.

vs OBX

Market Cap

$14.46M

Operating Cash Flow Yield

3.63%

TTM Avg

3.56%

3Y Avg

3.56%

5Y Avg

3.56%

BFRG

Bullfrog AI Holdings, Inc. Common Stock

vs OBX

Market Cap

$12.78M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KPTI

Karyopharm Therapeutics Inc.

vs OBX

Market Cap

$14.73M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
Obsidian Therapeutics Inc. (OBX)	$13.75M	N/A	N/A	N/A	N/A
Sintx Technologies, Inc. (SINT)vs ›	$13.86M	N/A	N/A	N/A	N/A
Pulsenmore Ltd. Ordinary Shares (PLSM)vs ›	$14.05M	N/A	N/A	N/A	N/A
IN8bio, Inc. (INAB)vs ›	$13.33M	N/A	N/A	N/A	N/A
Optimi Health Corp. (OPTH)vs ›	$13.30M	N/A	N/A	N/A	N/A
Citius Pharmaceuticals, Inc. (CTXR)vs ›	$13.20M	N/A	N/A	N/A	N/A
Passage Bio, Inc. (PASG)vs ›	$13.11M	N/A	N/A	N/A	N/A
Vyome Holdings, Inc. (HIND)vs ›	$14.46M	3.63%	3.56%	3.56%	3.56%
Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›	$12.78M	N/A	N/A	N/A	N/A
Karyopharm Therapeutics Inc. (KPTI)vs ›	$14.73M	N/A	N/A	N/A	N/A

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

OBX Operating Cash Flow Yield Metrics

OBX Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics